首页 > 最新文献

Tuberculosis最新文献

英文 中文
Migrations and Tuberculosis: A comparative study of Mycobacterium tuberculosis genomic population structure in Brazil and Mozambique to historical triangular slave trade knowledge to reconstruct the origins of tuberculosis infections caused by Lineage 1 in Brazil 移民和结核病:巴西和莫桑比克结核分枝杆菌基因组群体结构与历史三角奴隶贸易知识的比较研究,以重建巴西1系引起的结核病感染的起源
IF 2.9 3区 医学 Q3 IMMUNOLOGY Pub Date : 2026-01-05 DOI: 10.1016/j.tube.2026.102734
Thibaut Morel-Journel , Christophe Guyeux , Christophe Sola
Lineage 1 is an ancestral lineage of the Mycobacterium tuberculosis complex (MTBC) comprising five sublineages. In a previous study, we suggested that a representative of sublineage L1.1.3, present in both Mozambique and northern Brazil, SIT129, may have been brought to Brazil by sea during the long history of slavery that lasted, between Africa and Brazil, from the early 16th century to the mid-19th century. In this study, using a combination of new comparative genomics results and human migration data extracted from the SlaveVoyages.org database, we sought to more precisely reconstruct the scenario for the introduction of L1 genotypes into Brazil. We present results showing substantial similarities between the MTBC population structure in present-day Mozambique and Brazil across three subclades, L1.1.2, L1.1.3, and L1.2.2, and convergent historical data. Indeed, several introductions between the 16th and 19th centuries could explain the higher contemporary prevalence of L1 in northern Brazil. Our data do not allow us to decide between a direct introduction of L1 isolates into northern Brazil and intra-Brazilian transmission from the main southern ports, which seems likely. Other less likely scenarios are also discussed.
谱系1是结核分枝杆菌复合体(MTBC)的祖先谱系,包括五个亚谱系。在之前的一项研究中,我们提出,在16世纪早期到19世纪中期,非洲和巴西之间漫长的奴隶制历史中,存在于莫桑比克和巴西北部的L1.1.3次血统的代表SIT129可能是通过海路带到巴西的。在这项研究中,我们结合了新的比较基因组学结果和从SlaveVoyages.org数据库中提取的人类迁移数据,试图更精确地重建L1基因型引入巴西的情景。我们的研究结果显示,现今莫桑比克和巴西的MTBC种群结构在L1.1.2、L1.1.3和L1.2.2三个亚支上具有实质性的相似性,并且历史数据趋同。事实上,16世纪和19世纪之间的几次引进可以解释L1在巴西北部当代较高的流行率。我们的数据不允许我们决定是将L1分离株直接引入巴西北部,还是从南部主要港口在巴西境内传播,这似乎是可能的。还讨论了其他不太可能发生的情况。
{"title":"Migrations and Tuberculosis: A comparative study of Mycobacterium tuberculosis genomic population structure in Brazil and Mozambique to historical triangular slave trade knowledge to reconstruct the origins of tuberculosis infections caused by Lineage 1 in Brazil","authors":"Thibaut Morel-Journel ,&nbsp;Christophe Guyeux ,&nbsp;Christophe Sola","doi":"10.1016/j.tube.2026.102734","DOIUrl":"10.1016/j.tube.2026.102734","url":null,"abstract":"<div><div>Lineage 1 is an ancestral lineage of the <em>Mycobacterium tuberculosis</em> complex (MTBC) comprising five sublineages. In a previous study, we suggested that a representative of sublineage L1.1.3, present in both Mozambique and northern Brazil, SIT129, may have been brought to Brazil by sea during the long history of slavery that lasted, between Africa and Brazil, from the early 16th century to the mid-19th century. In this study, using a combination of new comparative genomics results and human migration data extracted from the <span><span>SlaveVoyages.org</span><svg><path></path></svg></span> database, we sought to more precisely reconstruct the scenario for the introduction of L1 genotypes into Brazil. We present results showing substantial similarities between the MTBC population structure in present-day Mozambique and Brazil across three subclades, L1.1.2, L1.1.3, and L1.2.2, and convergent historical data. Indeed, several introductions between the 16th and 19th centuries could explain the higher contemporary prevalence of L1 in northern Brazil. Our data do not allow us to decide between a direct introduction of L1 isolates into northern Brazil and intra-Brazilian transmission from the main southern ports, which seems likely. Other less likely scenarios are also discussed.</div></div>","PeriodicalId":23383,"journal":{"name":"Tuberculosis","volume":"157 ","pages":"Article 102734"},"PeriodicalIF":2.9,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145915297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic evaluation of a novel recombinant multi-epitope protein for paucibacillary and multibacillary leprosy 一种新型重组多表位蛋白对少杆菌性和多杆菌性麻风病的诊断评价
IF 2.9 3区 医学 Q3 IMMUNOLOGY Pub Date : 2026-01-05 DOI: 10.1016/j.tube.2026.102732
César N. Pereira , Raquel S.B. Câmara , Daniela P. Lage , Laís V.A. Corrêa , Camila S. Freitas , Ana L. Silva , Nathália C. Galvani , Mariana M. Cardoso , Bárbara P.N. Assis , Miguel A. Chávez-Fumagalli , Ricardo A. Machado-de-Ávila , Alexsandro S. Galdino , Unaí Tupinambás , Lílian L. Bueno , Ricardo T. Fujiwara , Manoel O. da Costa Rocha , Denise U. Gonçalves , Myron Christodoulides , Ana T. Chaves , Eduardo A.F. Coelho , Isabela A.G. Pereira
The diagnosis of leprosy remains challenging due to its clinical similarity with other infectious diseases and the variable sensitivity and specificity of current laboratory tests. Therefore, the identification and/or development of novel antigens is crucial for improving diagnostic accuracy. In this study, we designed a novel recombinant multi-polypeptide construct, termed M3, which was composed of specific B-cell epitopes from nine Mycobacterium leprae proteins, previously shown to be antigenic in leprosy. The recombinant M3 protein was expressed, purified, and evaluated as an antigen for the diagnosis of both paucibacillary (PB) and multibacillary (MB) disease, by using paired serum and urine samples from 380 participants. ELISA was performed using samples from PB (n = 50) and MB (n = 55) leprosy patients, their household contacts [PBC (n = 30) and MBC (n = 40), respectively], healthy individuals living in endemic region (n = 55), and patients with visceral (n = 30) and tegumentary (n = 45) leishmaniasis, Chagas disease (n = 35), tuberculosis (n = 15), and HIV-infection (n = 25). In serum-based ELISA, M3 showed sensitivity, specificity, positive and negative predictive values, and Youden index of 94.5 %, 100 %, 96.8 %, 97.4 %, and 0.91, respectively; whilst in a urine-based ELISA, the corresponding values were 96.4 %, 100 %, 98.8 %, 98.2 %, and 0.96, respectively. Additionally, paired serum and urine samples from 15 PB and 20 MB patients collected before and after treatment, revealed that anti-M3 antibodies decreased by more than 50 % post-therapy when using both analytes. These pilot findings suggest a potential biological role of the recombinant M3 protein for diagnosis of PB and MB leprosy.
麻风病的诊断仍然具有挑战性,因为它与其他传染病的临床相似,而且目前实验室检测的敏感性和特异性各不相同。因此,鉴定和/或开发新的抗原对提高诊断准确性至关重要。在这项研究中,我们设计了一种新的重组多肽结构,称为M3,它由9种麻风分枝杆菌蛋白的特异性b细胞表位组成,这些蛋白先前被证明在麻风中具有抗原性。表达、纯化重组M3蛋白,并通过380名参与者的配对血清和尿液样本,评估其作为诊断少杆菌病(PB)和多杆菌病(MB)的抗原。采用酶联免疫吸附试验(ELISA)对PB (n = 50)和MB (n = 55)麻风患者、其家庭接触者[PBC (n = 30)和MBC (n = 40)]、疫区健康人群(n = 55)、内脏利什曼病(n = 30)和腹腔利什曼病(n = 45)、恰加斯病(n = 35)、结核病(n = 15)和hiv感染(n = 25)患者进行检测。在基于血清的ELISA中,M3的敏感性、特异性、阳性预测值和阴性预测值分别为94.5%、100%、96.8%、97.4%和0.91;而以尿为基础的酶联免疫吸附试验的相应值分别为96.4%、100%、98.8%、98.2%和0.96。此外,在治疗前后收集的15例PB和20例MB患者的配对血清和尿液样本显示,使用这两种分析物后,抗m3抗体降低了50%以上。这些初步研究结果表明重组M3蛋白在诊断PB和MB麻风方面具有潜在的生物学作用。
{"title":"Diagnostic evaluation of a novel recombinant multi-epitope protein for paucibacillary and multibacillary leprosy","authors":"César N. Pereira ,&nbsp;Raquel S.B. Câmara ,&nbsp;Daniela P. Lage ,&nbsp;Laís V.A. Corrêa ,&nbsp;Camila S. Freitas ,&nbsp;Ana L. Silva ,&nbsp;Nathália C. Galvani ,&nbsp;Mariana M. Cardoso ,&nbsp;Bárbara P.N. Assis ,&nbsp;Miguel A. Chávez-Fumagalli ,&nbsp;Ricardo A. Machado-de-Ávila ,&nbsp;Alexsandro S. Galdino ,&nbsp;Unaí Tupinambás ,&nbsp;Lílian L. Bueno ,&nbsp;Ricardo T. Fujiwara ,&nbsp;Manoel O. da Costa Rocha ,&nbsp;Denise U. Gonçalves ,&nbsp;Myron Christodoulides ,&nbsp;Ana T. Chaves ,&nbsp;Eduardo A.F. Coelho ,&nbsp;Isabela A.G. Pereira","doi":"10.1016/j.tube.2026.102732","DOIUrl":"10.1016/j.tube.2026.102732","url":null,"abstract":"<div><div>The diagnosis of leprosy remains challenging due to its clinical similarity with other infectious diseases and the variable sensitivity and specificity of current laboratory tests. Therefore, the identification and/or development of novel antigens is crucial for improving diagnostic accuracy. In this study, we designed a novel recombinant multi-polypeptide construct, termed M3, which was composed of specific B-cell epitopes from nine <em>Mycobacterium leprae</em> proteins, previously shown to be antigenic in leprosy. The recombinant M3 protein was expressed, purified, and evaluated as an antigen for the diagnosis of both paucibacillary (PB) and multibacillary (MB) disease, by using paired serum and urine samples from 380 participants. ELISA was performed using samples from PB (n = 50) and MB (n = 55) leprosy patients, their household contacts [PBC (n = 30) and MBC (n = 40), respectively], healthy individuals living in endemic region (n = 55), and patients with visceral (n = 30) and tegumentary (n = 45) leishmaniasis, Chagas disease (n = 35), tuberculosis (n = 15), and HIV-infection (n = 25). In serum-based ELISA, M3 showed sensitivity, specificity, positive and negative predictive values, and Youden index of 94.5 %, 100 %, 96.8 %, 97.4 %, and 0.91, respectively; whilst in a urine-based ELISA, the corresponding values were 96.4 %, 100 %, 98.8 %, 98.2 %, and 0.96, respectively. Additionally, paired serum and urine samples from 15 PB and 20 MB patients collected before and after treatment, revealed that anti-M3 antibodies decreased by more than 50 % post-therapy when using both analytes. These pilot findings suggest a potential biological role of the recombinant M3 protein for diagnosis of PB and MB leprosy.</div></div>","PeriodicalId":23383,"journal":{"name":"Tuberculosis","volume":"157 ","pages":"Article 102732"},"PeriodicalIF":2.9,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145915296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reverse zoonosis in bovine tuberculosis: The neglected threat of Mycobacterium tuberculosis infection in cattle 牛结核中的逆行人畜共患病:牛结核分枝杆菌感染的被忽视的威胁
IF 2.9 3区 医学 Q3 IMMUNOLOGY Pub Date : 2026-01-05 DOI: 10.1016/j.tube.2026.102731
Vaishnavi Vivekanandan , Arun K , Sindhu Hasini Doredla , Harini Ramanujam , Ranjani Singaraj , Kannan Palaniyandi
Tuberculosis (TB), caused by members of the Mycobacterium tuberculosis complex (MTBC), remains a significant global health concern. While zoonotic transmission of M. bovis from cattle to humans is well documented, reverse zoonotic transmission of M. tuberculosis from humans to cattle has received far less attention. This review provides the first comprehensive synthesis of M. tuberculosis infections in cattle, drawing on evidence from farms, households, and slaughterhouses where human–animal contact is most intense. Available data indicate that such spillover events are uncommon compared with M. bovis infection, and that infectious humans—via aerosols or sputum-contaminated feed or environments—represent the primary, and likely exclusive source of infection for cattle, as no sustained cattle-to-cattle transmission has been reported. Experimental M. tuberculosis infection in cattle consistently demonstrates an attenuated phenotype, with mild pathology and low bacterial loads. However, the identification of multidrug-resistant and pre–extensively drug-resistant M. tuberculosis strains in cattle raises a potential future concern regarding cross-species transmission, despite the fact that transmission back to humans has not been observed yet. Enhancing routine molecular diagnostics is vital for precise MTBC differentiation and a better grasp of cross-species transmission dynamics. A unified One Health strategy, which combines human, animal, and environmental monitoring, is essential to track and address this emerging threat.
由结核分枝杆菌复合体(MTBC)成员引起的结核病(TB)仍然是一个重大的全球卫生问题。虽然牛分枝杆菌的人畜共患传播已得到充分记录,但结核分枝杆菌从人到牛的人畜共患反向传播却受到的关注少得多。本综述利用来自人与动物接触最密切的农场、家庭和屠宰场的证据,首次全面综合了牛中结核分枝杆菌感染情况。现有数据表明,与牛支原体感染相比,这种外溢事件并不常见,而且由于没有报告持续的牛与牛之间的传播,具有传染性的人(通过气溶胶或痰污染的饲料或环境)是牛的主要和可能的唯一感染源。牛的实验性结核分枝杆菌感染一贯表现为减毒表型,具有轻度病理和低细菌负荷。然而,牛中多重耐药和预广泛耐药结核分枝杆菌菌株的鉴定引起了未来对跨物种传播的潜在关注,尽管尚未观察到传播回人类的事实。加强常规分子诊断对于精确区分MTBC和更好地掌握跨物种传播动态至关重要。统一的“同一个健康”战略结合了对人类、动物和环境的监测,对于跟踪和应对这一新出现的威胁至关重要。
{"title":"Reverse zoonosis in bovine tuberculosis: The neglected threat of Mycobacterium tuberculosis infection in cattle","authors":"Vaishnavi Vivekanandan ,&nbsp;Arun K ,&nbsp;Sindhu Hasini Doredla ,&nbsp;Harini Ramanujam ,&nbsp;Ranjani Singaraj ,&nbsp;Kannan Palaniyandi","doi":"10.1016/j.tube.2026.102731","DOIUrl":"10.1016/j.tube.2026.102731","url":null,"abstract":"<div><div>Tuberculosis (TB), caused by members of the <em>Mycobacterium tuberculosis</em> complex (MTBC), remains a significant global health concern. While zoonotic transmission of <em>M. bovis</em> from cattle to humans is well documented, reverse zoonotic transmission of <em>M. tuberculosis</em> from humans to cattle has received far less attention. This review provides the first comprehensive synthesis of <em>M. tuberculosis</em> infections in cattle, drawing on evidence from farms, households, and slaughterhouses where human–animal contact is most intense. Available data indicate that such spillover events are uncommon compared with <em>M. bovis</em> infection, and that infectious humans—via aerosols or sputum-contaminated feed or environments—represent the primary, and likely exclusive source of infection for cattle, as no sustained cattle-to-cattle transmission has been reported. Experimental <em>M. tuberculosis</em> infection in cattle consistently demonstrates an attenuated phenotype, with mild pathology and low bacterial loads. However, the identification of multidrug-resistant and pre–extensively drug-resistant <em>M. tuberculosis</em> strains in cattle raises a potential future concern regarding cross-species transmission, despite the fact that transmission back to humans has not been observed yet. Enhancing routine molecular diagnostics is vital for precise MTBC differentiation and a better grasp of cross-species transmission dynamics. A unified One Health strategy, which combines human, animal, and environmental monitoring, is essential to track and address this emerging threat.</div></div>","PeriodicalId":23383,"journal":{"name":"Tuberculosis","volume":"157 ","pages":"Article 102731"},"PeriodicalIF":2.9,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145929116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting the antigen 85 complex of Mycobacterium tuberculosis: A three-fold validation of antimycobacterial activity of Centella asiatica 针对结核分枝杆菌抗原85复合体:积雪草抑菌活性的三重验证
IF 2.9 3区 医学 Q3 IMMUNOLOGY Pub Date : 2026-01-05 DOI: 10.1016/j.tube.2026.102736
Risha Hazarika , Sanjukta Patra

Introduction

One of the biggest challenges associated with tuberculosis is the emerging drug resistance which emphasizes the need of alternative therapeutic approaches. In recent years, multitargeting approach for TB therapy has garnered considerable attention. The Antigen85 complex of proteins represent key enzymes which are involved in Mtb cell wall biosynthesis. This study aims at investigating the antimycobacterial effects of Centella asiatica and its two compounds - asiatic acid and quercetin against these three proteins and validate them as multi targets for drug targeting.

Methods

Three-fold validation approach included in-silico studies, in-vitro inhibitory studies against MtbH37Ra strain and inhibition studies against recombinant enzymes.

Results

Displaying good bioavailability, asiatic acid and quercetin exhibited favorable binding affinities. Disruption of the integrity of the cell membrane of MtbH37Ra was observed through electron microscopy and flow cytometry. Both compounds and extract showed inhibitory activity against the enzymes and microorganism and were found to act synergistically in conjunction with isoniazid. Asiatic acid demonstrated bactericidal activity. The reduced reaction rate of the recombinant enzymes implied their function and activity were hampered, which was confirmed through a fluorometric assay.

Conclusion

These results highlight the potential of asiatic acid and quercetin as multitarget inhibitors of the Mtb Antigen85 complex.
与结核病相关的最大挑战之一是新出现的耐药性,这强调了替代治疗方法的必要性。近年来,多靶点结核病治疗方法引起了相当大的关注。抗原85蛋白复合体是参与结核分枝杆菌细胞壁生物合成的关键酶。本研究旨在探讨积雪草及其化合物积雪草酸和槲皮素对这三种蛋白的抑菌作用,并验证其作为多靶点的药物靶向性。方法采用三重验证法,包括计算机实验、对MtbH37Ra菌株的体外抑制实验和对重组酶的抑制实验。结果亚洲果酸与槲皮素具有良好的结合亲和力,具有良好的生物利用度。电镜和流式细胞术观察到mbh37ra细胞膜完整性的破坏。化合物和提取物均表现出对酶和微生物的抑制活性,并与异烟肼协同作用。亚细亚酸显示出杀菌活性。重组酶的反应速率降低意味着其功能和活性受到阻碍,通过荧光分析证实了这一点。结论亚洲果酸和槲皮素可作为结核分枝杆菌抗原85复合物的多靶点抑制剂。
{"title":"Targeting the antigen 85 complex of Mycobacterium tuberculosis: A three-fold validation of antimycobacterial activity of Centella asiatica","authors":"Risha Hazarika ,&nbsp;Sanjukta Patra","doi":"10.1016/j.tube.2026.102736","DOIUrl":"10.1016/j.tube.2026.102736","url":null,"abstract":"<div><h3>Introduction</h3><div>One of the biggest challenges associated with tuberculosis is the emerging drug resistance which emphasizes the need of alternative therapeutic approaches. In recent years, multitargeting approach for TB therapy has garnered considerable attention. The Antigen85 complex of proteins represent key enzymes which are involved in <em>Mtb</em> cell wall biosynthesis. This study aims at investigating the antimycobacterial effects of <em>Centella asiatica</em> and its two compounds - asiatic acid and quercetin against these three proteins and validate them as multi targets for drug targeting.</div></div><div><h3>Methods</h3><div>Three-fold validation approach included <em>in-silico</em> studies, <em>in-vitro</em> inhibitory studies against <em>Mtb</em>H37Ra strain and inhibition studies against recombinant enzymes.</div></div><div><h3>Results</h3><div>Displaying good bioavailability, asiatic acid and quercetin exhibited favorable binding affinities. Disruption of the integrity of the cell membrane of <em>Mtb</em>H37Ra was observed through electron microscopy and flow cytometry. Both compounds and extract showed inhibitory activity against the enzymes and microorganism and were found to act synergistically in conjunction with isoniazid. Asiatic acid demonstrated bactericidal activity. The reduced reaction rate of the recombinant enzymes implied their function and activity were hampered, which was confirmed through a fluorometric assay.</div></div><div><h3>Conclusion</h3><div>These results highlight the potential of asiatic acid and quercetin as multitarget inhibitors of the <em>Mtb</em> Antigen85 complex.</div></div>","PeriodicalId":23383,"journal":{"name":"Tuberculosis","volume":"157 ","pages":"Article 102736"},"PeriodicalIF":2.9,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146038669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First confirmation of Mycobacterium tuberculosis complex from medieval Ireland by aDNA analysis – palaeopathological and microbial findings 首次确认结核分枝杆菌复合体从中世纪爱尔兰通过aDNA分析-古病理和微生物的发现。
IF 2.9 3区 医学 Q3 IMMUNOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.tube.2025.102710
Eileen M. Murphy , G. Michael Taylor , Tom A. Mendum , Graham R. Stewart
Eight burials from the multi-period rural settlement site of Ranelagh near Roscommon town, Ireland, with palaeopathological lesions suggestive of skeletal tuberculosis or brucellosis were examined by ancient DNA (aDNA) testing. Tuberculosis infection (MTB complex DNA) was confirmed in five individuals – an 11th-13th CE adolescent female (14.5–17.5 years), two young adults females (18–35 years, 7th-10th CE), one adolescent of unknown sex and one middle-aged adult (35–50 years, medieval in date). In the latter case, the differential diagnosis included brucellosis due to the presence of small multifocal lytic lesions in the lower spinal vertebrae. However, this individual and all cases tested negative for Brucella species DNA. In two positive cases, lineage 4 (Euro-American) Mycobacterium tuberculosis DNA was identified in extracts obtained from tooth pulp cavities. These are the first archaeological individuals from Ireland to have had tuberculosis infection confirmed through aDNA analysis.
通过古DNA (aDNA)测试,对爱尔兰罗斯科蒙镇附近Ranelagh多时期农村居民点的8个墓葬进行了检查,这些墓葬具有提示骨骼结核或布鲁氏菌病的古病理学病变。5例确诊结核感染(MTB复体DNA): 1例11 -13 CE青春期女性(14.5-17.5岁),2例青壮年女性(18-35岁,7 -10 CE), 1例性别未知的青少年和1例中年成人(35-50岁,中世纪)。在后一种情况下,鉴别诊断包括布鲁氏菌病,因为在脊柱下部椎骨存在小的多灶性溶解性病变。然而,该个体和所有病例的布鲁氏菌种DNA检测呈阴性。在两例阳性病例中,从牙髓腔提取液中鉴定出谱系4(欧美)结核分枝杆菌DNA。这是爱尔兰第一批通过dna分析证实患有结核病的考古个体。
{"title":"First confirmation of Mycobacterium tuberculosis complex from medieval Ireland by aDNA analysis – palaeopathological and microbial findings","authors":"Eileen M. Murphy ,&nbsp;G. Michael Taylor ,&nbsp;Tom A. Mendum ,&nbsp;Graham R. Stewart","doi":"10.1016/j.tube.2025.102710","DOIUrl":"10.1016/j.tube.2025.102710","url":null,"abstract":"<div><div>Eight burials from the multi-period rural settlement site of Ranelagh near Roscommon town, Ireland, with palaeopathological lesions suggestive of skeletal tuberculosis or brucellosis were examined by ancient DNA (aDNA) testing. Tuberculosis infection (MTB complex DNA) was confirmed in five individuals – an 11th-13th CE adolescent female (14.5–17.5 years), two young adults females (18–35 years, 7th-10th CE), one adolescent of unknown sex and one middle-aged adult (35–50 years, medieval in date). In the latter case, the differential diagnosis included brucellosis due to the presence of small multifocal lytic lesions in the lower spinal vertebrae. However, this individual and all cases tested negative for <em>Brucella</em> species DNA. In two positive cases, lineage 4 (Euro-American) <em>Mycobacterium tuberculosis</em> DNA was identified in extracts obtained from tooth pulp cavities. These are the first archaeological individuals from Ireland to have had tuberculosis infection confirmed through aDNA analysis.</div></div>","PeriodicalId":23383,"journal":{"name":"Tuberculosis","volume":"156 ","pages":"Article 102710"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Inhibition of mycobacteria proliferation in macrophages by diaryl ether derivatives of Dehydrozingerone compound and repurposed drugs (Rebamipide, Sofalcone) via NF-κB pathway inhibition” [Tuberculosis, 155(2025), 102706] “Dehydrozingerone化合物二芳基醚衍生物和重组药物(Rebamipide, Sofalcone)通过抑制NF-κB途径抑制巨噬细胞分枝杆菌增殖”的更正”[tb, 155(2025), 102706]
IF 2.9 3区 医学 Q3 IMMUNOLOGY Pub Date : 2025-12-19 DOI: 10.1016/j.tube.2025.102722
Safiya Mehraj , Shazia Ali , Chetan Kumar , Asif Ali , Zahoor Ahmad
{"title":"Corrigendum to “Inhibition of mycobacteria proliferation in macrophages by diaryl ether derivatives of Dehydrozingerone compound and repurposed drugs (Rebamipide, Sofalcone) via NF-κB pathway inhibition” [Tuberculosis, 155(2025), 102706]","authors":"Safiya Mehraj ,&nbsp;Shazia Ali ,&nbsp;Chetan Kumar ,&nbsp;Asif Ali ,&nbsp;Zahoor Ahmad","doi":"10.1016/j.tube.2025.102722","DOIUrl":"10.1016/j.tube.2025.102722","url":null,"abstract":"","PeriodicalId":23383,"journal":{"name":"Tuberculosis","volume":"156 ","pages":"Article 102722"},"PeriodicalIF":2.9,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145791078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to “Constructive appraisal of Zhong et al.’s study on Mycobacterium tuberculosis dormant antigens and PB2-DIMQ vaccine: Opportunities for translational strengthening” 对Zhong等人关于结核分枝杆菌休眠抗原和PB2-DIMQ疫苗研究的建设性评价:加强翻译的机会的回应。
IF 2.9 3区 医学 Q3 IMMUNOLOGY Pub Date : 2025-12-18 DOI: 10.1016/j.tube.2025.102723
Qiangsen Zhong , Xiaochun Wang , Yun Xu , Runlin Wang , Mingming Zhou , Xinkuang Liu
{"title":"Response to “Constructive appraisal of Zhong et al.’s study on Mycobacterium tuberculosis dormant antigens and PB2-DIMQ vaccine: Opportunities for translational strengthening”","authors":"Qiangsen Zhong ,&nbsp;Xiaochun Wang ,&nbsp;Yun Xu ,&nbsp;Runlin Wang ,&nbsp;Mingming Zhou ,&nbsp;Xinkuang Liu","doi":"10.1016/j.tube.2025.102723","DOIUrl":"10.1016/j.tube.2025.102723","url":null,"abstract":"","PeriodicalId":23383,"journal":{"name":"Tuberculosis","volume":"156 ","pages":"Article 102723"},"PeriodicalIF":2.9,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145828394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasma biomarkers CRP, iFABP, and zonulin as predictors of tuberculosis progression in household contacts of pulmonary TB patients 血浆生物标志物CRP、iFABP和zonulin作为肺结核患者家庭接触者结核病进展的预测因子
IF 2.9 3区 医学 Q3 IMMUNOLOGY Pub Date : 2025-12-11 DOI: 10.1016/j.tube.2025.102720
Anuradha Rajamanickam , Evangeline Ann Daniel , Nikhil Gupte , Kannan Thiruvengadam , Padmapriyadarsini Chandrasekaran , Sathyamurthi Pattabiraman , Brindha Bhanu , Amsaveni Sivaprakasam , Mandar Paradkar , Vandana Kulkarni , Rajesh Karyakarte , Vidya Mave , Amita Gupta , Luke Elizabeth Hanna , Subash Babu

Background

Identifying host biomarkers associated with progression from Mycobacterium tuberculosis infection to active tuberculosis (TB) could support early risk stratification in household contacts (HHCs). This exploratory study evaluated baseline plasma immune biomarkers in HHCs of pulmonary TB (PTB) patients to assess their association with subsequent disease development.

Methods

We analyzed baseline plasma samples from 15 progressors and 29 non-progressors enrolled from PTB-affected households. Acute-phase proteins (α-2-macroglobulin (α-2-M), C-reactive protein [CRP], haptoglobin (Hp), serum amyloid P (SAP)) and microbial translocation markers (lipopolysaccharide, lipid-binding protein, endotoxin core antibodies IgG, intestinal fatty acid-binding protein [iFABP], sCD14, and zonulin) were measured using Luminex and ELISA. Logistic regression and ROC analyses were performed as exploratory assessments of biomarker associations.

Results

Higher baseline levels of CRP, iFABP, and zonulin were observed among progressors compared with non-progressors. In univariable analyses, these biomarkers showed strong discriminatory ability (AUC ≥0.90), although estimates should be interpreted cautiously given the small sample size. A combined model including CRP, iFABP, and zonulin demonstrated high discriminatory performance (AUC 0.99 [95 % CI: 0.97–1.00]), but confidence intervals reflect the imprecision inherent to the limited dataset.

Conclusions

In this exploratory cohort, elevated CRP, iFABP, and zonulin were associated with progression to active TB among household contacts. These preliminary findings suggest potential involvement of inflammatory and gut-barrier pathways in TB progression and warrant validation in larger, independent cohorts to define their translational utility.
背景:鉴定与结核分枝杆菌感染进展为活动性结核病(TB)相关的宿主生物标志物可以支持家庭接触者(hhc)的早期风险分层。本探索性研究评估了肺结核(PTB)患者hhc的基线血浆免疫生物标志物,以评估其与随后疾病发展的相关性。方法:我们分析了来自受ptb影响家庭的15名进展者和29名非进展者的基线血浆样本。采用Luminex和ELISA检测急性期蛋白(α-2-巨球蛋白(α-2-M)、c反应蛋白(CRP)、接触珠蛋白(Hp)、血清淀粉样蛋白(SAP))和微生物易位标志物(脂多糖、脂结合蛋白、内毒素核心抗体IgG、肠脂肪酸结合蛋白(iFABP)、sCD14、zonulin)。采用Logistic回归和ROC分析作为生物标志物相关性的探索性评估。结果:与非进展者相比,在进展者中观察到更高的CRP、iFABP和zonulin基线水平。在单变量分析中,这些生物标志物显示出很强的区分能力(AUC≥0.90),尽管由于样本量小,估计值应谨慎解释。包括CRP、iFABP和zonulin的组合模型显示出很高的区分性能(AUC 0.99 [95% CI: 0.97-1.00]),但置信区间反映了有限数据集固有的不精确性。结论:在这个探索性队列中,升高的CRP、iFABP和zonulin与家庭接触者发展为活动性结核病有关。这些初步发现表明炎症和肠道屏障通路可能参与结核病的进展,并需要在更大的独立队列中进行验证,以确定其转化效用。
{"title":"Plasma biomarkers CRP, iFABP, and zonulin as predictors of tuberculosis progression in household contacts of pulmonary TB patients","authors":"Anuradha Rajamanickam ,&nbsp;Evangeline Ann Daniel ,&nbsp;Nikhil Gupte ,&nbsp;Kannan Thiruvengadam ,&nbsp;Padmapriyadarsini Chandrasekaran ,&nbsp;Sathyamurthi Pattabiraman ,&nbsp;Brindha Bhanu ,&nbsp;Amsaveni Sivaprakasam ,&nbsp;Mandar Paradkar ,&nbsp;Vandana Kulkarni ,&nbsp;Rajesh Karyakarte ,&nbsp;Vidya Mave ,&nbsp;Amita Gupta ,&nbsp;Luke Elizabeth Hanna ,&nbsp;Subash Babu","doi":"10.1016/j.tube.2025.102720","DOIUrl":"10.1016/j.tube.2025.102720","url":null,"abstract":"<div><h3>Background</h3><div>Identifying host biomarkers associated with progression from <em>Mycobacterium tuberculosis</em> infection to active tuberculosis (TB) could support early risk stratification in household contacts (HHCs). This exploratory study evaluated baseline plasma immune biomarkers in HHCs of pulmonary TB (PTB) patients to assess their association with subsequent disease development.</div></div><div><h3>Methods</h3><div>We analyzed baseline plasma samples from 15 progressors and 29 non-progressors enrolled from PTB-affected households. Acute-phase proteins (α-2-macroglobulin (α-2-M), C-reactive protein [CRP], haptoglobin (Hp), serum amyloid P (SAP)) and microbial translocation markers (lipopolysaccharide, lipid-binding protein, endotoxin core antibodies IgG, intestinal fatty acid-binding protein [iFABP], sCD14, and zonulin) were measured using Luminex and ELISA. Logistic regression and ROC analyses were performed as exploratory assessments of biomarker associations.</div></div><div><h3>Results</h3><div>Higher baseline levels of CRP, iFABP, and zonulin were observed among progressors compared with non-progressors. In univariable analyses, these biomarkers showed strong discriminatory ability (AUC ≥0.90), although estimates should be interpreted cautiously given the small sample size. A combined model including CRP, iFABP, and zonulin demonstrated high discriminatory performance (AUC 0.99 [95 % CI: 0.97–1.00]), but confidence intervals reflect the imprecision inherent to the limited dataset.</div></div><div><h3>Conclusions</h3><div>In this exploratory cohort, elevated CRP, iFABP, and zonulin were associated with progression to active TB among household contacts. These preliminary findings suggest potential involvement of inflammatory and gut-barrier pathways in TB progression and warrant validation in larger, independent cohorts to define their translational utility.</div></div>","PeriodicalId":23383,"journal":{"name":"Tuberculosis","volume":"156 ","pages":"Article 102720"},"PeriodicalIF":2.9,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145782650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Responses to comments on “A comparative study between milk- and serum-based antibody detection assays for Johne's disease in New Zealand dairy cattle” 对“新西兰奶牛约翰氏病乳基抗体检测与血清抗体检测的比较研究”评论的答复
IF 2.9 3区 医学 Q3 IMMUNOLOGY Pub Date : 2025-12-11 DOI: 10.1016/j.tube.2025.102721
K.M. Venkatesh , Nicolas Lopez-Villalobos , Sandeep K. Gupta , Garry B. Udy , Richard Laven , Shih-Jiuan Chiu , Piyush Bugde , Yoichi Furuya , Venkata Sayoji Rao Dukkipati
{"title":"Responses to comments on “A comparative study between milk- and serum-based antibody detection assays for Johne's disease in New Zealand dairy cattle”","authors":"K.M. Venkatesh ,&nbsp;Nicolas Lopez-Villalobos ,&nbsp;Sandeep K. Gupta ,&nbsp;Garry B. Udy ,&nbsp;Richard Laven ,&nbsp;Shih-Jiuan Chiu ,&nbsp;Piyush Bugde ,&nbsp;Yoichi Furuya ,&nbsp;Venkata Sayoji Rao Dukkipati","doi":"10.1016/j.tube.2025.102721","DOIUrl":"10.1016/j.tube.2025.102721","url":null,"abstract":"","PeriodicalId":23383,"journal":{"name":"Tuberculosis","volume":"156 ","pages":"Article 102721"},"PeriodicalIF":2.9,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145840561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on “A comparative study between milk- and serum-based antibody detection assays for Johne's disease in New Zealand dairy cattle” 对“新西兰奶牛约翰氏病乳抗体和血清抗体检测方法的比较研究”的评论。
IF 2.9 3区 医学 Q3 IMMUNOLOGY Pub Date : 2025-12-09 DOI: 10.1016/j.tube.2025.102719
Arun Kumar, Ankur Sharma, Saumya Das, Preeti Dnyandeo Sonje, Dhanya Dedeepya
{"title":"Comments on “A comparative study between milk- and serum-based antibody detection assays for Johne's disease in New Zealand dairy cattle”","authors":"Arun Kumar,&nbsp;Ankur Sharma,&nbsp;Saumya Das,&nbsp;Preeti Dnyandeo Sonje,&nbsp;Dhanya Dedeepya","doi":"10.1016/j.tube.2025.102719","DOIUrl":"10.1016/j.tube.2025.102719","url":null,"abstract":"","PeriodicalId":23383,"journal":{"name":"Tuberculosis","volume":"156 ","pages":"Article 102719"},"PeriodicalIF":2.9,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145775947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Tuberculosis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1